Kenneth Shain

Dr Kenneth Shain

Scientific Director, Moffitt Myelonma Working Group, Moffitt Cancer Center

To date, Dr. Shain has been actively participating in translation research in multiple myeloma and other hematologic malignancies, with 40 publications as well as a number of book chapters. Clinically, Dr. Shain is/has been the principal investigator and co-investigator of a number of clinical trials in multiple myeloma. His translational research has focused on the mechanisms by which components of the bone marrow microenvironment influence myeloma biology, survival, and drug response. He is currently collaborating with a wide range of Moffitt and non-Moffitt researchers, mathematicians, clinicians and other groups to carry out his research goals. 


Featured Speakers



evidera excelra genrubix signet at big data stemtrak

The event is a good opportunity for industry to come together and identify ways to understand and utilize big data in the advancement of patient care.

Dr Mark Roche, CEO, Avanti iHealth

Show the sponsors

Vote who is making waves in the industry!

Phacilitate will gather influencers and industry innovators together from across healthcare, academia, Big Pharma, government and technology innovators into an ebook. Find out more